Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 1516: The role of protein tyrosine kinases in DNA mismatch repair

View through CrossRef
Abstract The DNA mismatch repair (MMR) pathway and its regulation are necessary for genomic stability. Cells deficient in MMR exhibit increased expansion and contraction of short repeat sequences in the genome, termed microsatellite instability (MSI). Loss of MMR also results in resistance to certain classes of DNA damaging chemotherapeutics. The standard treatment option for most patients includes chemotherapy, which has toxic side effects. Immunotherapy has recently been utilized as a treatment for various cancers. MSI-high cancers respond better to immunotherapy treatment compared to microsatellite stable (MSS) cancers. This increased response is believed to be due to the higher mutation frequencies associated with the MSI-high tumors, which lead to greater neoantigen production. The primary proteins required for MMR are known, however regulation of the pathway is not well understood. The MLH1 protein is critical for MMR and is required for the excision licensing of the daughter DNA strand. Loss or mutation of MLH1 leads to defective MMR, increased mutation frequency, and MSI. Recent studies by our laboratory and others have shown that treatment with a tyrosine kinase inhibitor, Imatinib, leads to decreased MLH1 protein expression, and resistance to MMR-dependent apoptosis. These observations suggest a link between Imatinib-sensitive protein tyrosine kinases (PTKs) and the regulation of MMR. We show that MLH1 protein reduction is not occurring at the mRNA level and is thought to be post-transcriptional. We have identified the Imatinib sensitive target most likely responsible for the MLH1 reduction phenotype. We show that the target protein and MLH1 have a physical interaction that likely prevents degradation targeting of MLH1 by the Hsp70 chaperone. A detailed understanding of MMR regulation by PTKs would significantly advance the knowledge in the field of MMR and have important implications for immunotherapy strategies. Citation Format: Hannah Daniels, Breanna Knicely, Eva M. Goellner. The role of protein tyrosine kinases in DNA mismatch repair [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 1516.
American Association for Cancer Research (AACR)
Title: Abstract 1516: The role of protein tyrosine kinases in DNA mismatch repair
Description:
Abstract The DNA mismatch repair (MMR) pathway and its regulation are necessary for genomic stability.
Cells deficient in MMR exhibit increased expansion and contraction of short repeat sequences in the genome, termed microsatellite instability (MSI).
Loss of MMR also results in resistance to certain classes of DNA damaging chemotherapeutics.
The standard treatment option for most patients includes chemotherapy, which has toxic side effects.
Immunotherapy has recently been utilized as a treatment for various cancers.
MSI-high cancers respond better to immunotherapy treatment compared to microsatellite stable (MSS) cancers.
This increased response is believed to be due to the higher mutation frequencies associated with the MSI-high tumors, which lead to greater neoantigen production.
The primary proteins required for MMR are known, however regulation of the pathway is not well understood.
The MLH1 protein is critical for MMR and is required for the excision licensing of the daughter DNA strand.
Loss or mutation of MLH1 leads to defective MMR, increased mutation frequency, and MSI.
Recent studies by our laboratory and others have shown that treatment with a tyrosine kinase inhibitor, Imatinib, leads to decreased MLH1 protein expression, and resistance to MMR-dependent apoptosis.
These observations suggest a link between Imatinib-sensitive protein tyrosine kinases (PTKs) and the regulation of MMR.
We show that MLH1 protein reduction is not occurring at the mRNA level and is thought to be post-transcriptional.
We have identified the Imatinib sensitive target most likely responsible for the MLH1 reduction phenotype.
We show that the target protein and MLH1 have a physical interaction that likely prevents degradation targeting of MLH1 by the Hsp70 chaperone.
A detailed understanding of MMR regulation by PTKs would significantly advance the knowledge in the field of MMR and have important implications for immunotherapy strategies.
Citation Format: Hannah Daniels, Breanna Knicely, Eva M.
Goellner.
The role of protein tyrosine kinases in DNA mismatch repair [abstract].
In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13.
Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 1516.

Related Results

Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
Genome wide hypomethylation and youth-associated DNA gap reduction promoting DNA damage and senescence-associated pathogenesis
Genome wide hypomethylation and youth-associated DNA gap reduction promoting DNA damage and senescence-associated pathogenesis
Abstract Background: Age-associated epigenetic alteration is the underlying cause of DNA damage in aging cells. Two types of youth-associated DNA-protection epigenetic mark...
Echinococcus granulosus in Environmental Samples: A Cross-Sectional Molecular Study
Echinococcus granulosus in Environmental Samples: A Cross-Sectional Molecular Study
Abstract Introduction Echinococcosis, caused by tapeworms of the Echinococcus genus, remains a significant zoonotic disease globally. The disease is particularly prevalent in areas...
Endothelial Protein C Receptor
Endothelial Protein C Receptor
IntroductionThe protein C anticoagulant pathway plays a critical role in the negative regulation of the blood clotting response. The pathway is triggered by thrombin, which allows ...
HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas
HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas
Abstract Background Oral squamous cell carcinoma (OSCC) is the main type of oral cancer. Disturbing DNA repair is an invaluable way to improve the e...
Abstract 1265: Dysregulated tyrosine kinase Tyro3 signaling in acute myeloid leukemia
Abstract 1265: Dysregulated tyrosine kinase Tyro3 signaling in acute myeloid leukemia
Abstract The undesirable outcomes of classical chemotherapy approaches in the treatment of cancer pathogenesis has directed scientists to find more targeted and less...
Abstract 1613: Characterization of the Src-regulated kinome by chemical proteomics
Abstract 1613: Characterization of the Src-regulated kinome by chemical proteomics
Abstract Enhanced Src activation has been implicated in many cancers, including those of breast, lung and pancreas. However single-agent therapies targeting Src have...

Back to Top